Valeant

Page 11 of 12

J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Health

Short-seller: Is Valeant the pharmaceutical Enron?

By
October 21, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health

Valeant eases up on strategy to buy up ‘mispriced drugs’

By
October 19, 2015
Hedge fund manager Bill Ackman
Finance

The strange thing about Bill Ackman’s defense of Valeant’s drug prices

By
October 7, 2015
The drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
Health

The drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach

By
September 29, 2015
Valeant had the hots for ‘female Viagra,’ Sprout CEO says
MPW

Valeant had the hots for ‘female Viagra,’ Sprout CEO says

By
August 20, 2015
Ackman, founder and CEO of hedge fund Pershing Square Capital Management, speaks at the Sohn Investment Conference in New York
Finance

Bill Ackman: Valeant could be the next Berkshire Hathaway

By
May 4, 2015
SEC Chair Mary Jo White
Finance

SEC’s Mary Jo White criticizes shareholder activism and Bill Ackman deal

By
March 19, 2015
Actavis CEO Brenton Saunders and Allergan CEO David Pyotton pose together on the floor of the New York Stock Exchange
Finance

Allergan CEO: How to survive an activist attack

By
February 12, 2015
Actavis CEO Brenton Saunders and Allergan CEO David Pyotton pose together on the floor of the New York Stock Exchange
Finance

Allergan CEO hands Botox maker to lawyer instead of consultant

By
November 17, 2014
Botox
Finance

Actavis agrees to buy Botox-maker Allergan for $66 billion

By
November 17, 2014
Did Bill Ackman just kill the poison pill?
Finance

Did Bill Ackman just kill the poison pill?

By
November 6, 2014
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Bill Ackman confirms Pershing Square Holdings IPO plan

By
August 13, 2014
Morgan Stanley caught playing both sides of Allergan-Valeant fight
Finance

Morgan Stanley caught playing both sides of Allergan-Valeant fight

By
June 16, 2014
Botox Treatment
Finance

Allergan and Valeant are both hypocrites

By
June 2, 2014
Fortune
Finance

Valeant boosts bid to buy Botox-maker Allergan

By
May 28, 2014

Most Popular